Evidence map›Paper›PMID 41395567›Full record

ArticleInternational cancer conference journal2025

A case of primary ovarian clear cell carcinoma with

Daisuke Ochiai, Tatsuyuki Chiyoda, Kohei Nakamura, Reika Takamatsu, Mitsuyo Jisaka, Tomomi Sakamaki, Mio Takahashi, Yumiko Kimura, Shinya Oki, Tomoko Yoshihama and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International cancer conference journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daisuke OchiaiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Tatsuyuki ChiyodaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.ORCID 0000-0002-8214-2242
Kohei NakamuraCenter for Cancer Genomics, Keio University School of Medicine, Tokyo, 160-8582 Japan.
Reika TakamatsuCenter for Cancer Genomics, Keio University School of Medicine, Tokyo, 160-8582 Japan.
Mitsuyo JisakaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Tomomi SakamakiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Mio TakahashiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Yumiko KimuraDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Shinya OkiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Tomoko YoshihamaDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Kensuke SakaiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.
Hiroshi NishiharaCenter for Cancer Genomics, Keio University School of Medicine, Tokyo, 160-8582 Japan.
Wataru YamagamiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-Ku, Tokyo, 160-8582 Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first documented case of primary ovarian clear cell carcinoma harboring an

Indexed as

Clear cell carcinomaNTRK fusionOvarian cancer

Identifiers

PMID41395567
PMCPMC12696233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.